Top Suppliers:I want be here

2789629-84-9

2789629-84-9 structure
2789629-84-9 structure
  • Name: DCZ19931
  • Chemical Name: DCZ19931
  • CAS Number: 2789629-84-9
  • Molecular Formula: C26H20F5N3O5
  • Molecular Weight: 549.45
  • Catalog: Signaling Pathways MAPK/ERK Pathway ERK
  • Create Date: 2023-01-25 21:54:58
  • Modify Date: 2024-04-03 09:23:20
  • DCZ19931 is a potent multi-targeting kinase inhibitor. DCZ19931 has anti-angiogenic effects on ocular neovascularization. DCZ19931 also inhibits ERK1/2-MAPK and p38-MAPK signaling[1].

Name DCZ19931
Description DCZ19931 is a potent multi-targeting kinase inhibitor. DCZ19931 has anti-angiogenic effects on ocular neovascularization. DCZ19931 also inhibits ERK1/2-MAPK and p38-MAPK signaling[1].
Related Catalog
Target

ERK1

ERK2

p38 MAPK

In Vitro DCZ19931 (1 nM-10 μM; 24 h) 对人脐静脉内皮细胞 (HUVECs) 无明显的细胞毒性[1]。 DCZ19931 (500 nM; 24 h) 抑制 (10 ng/mL; 12 h) VEGFs 诱导的内皮细胞增殖、迁移和成管能力[1]。 DCZ19931 (500 nM; 24 h) 通过下调 ICAM-1,表达抑制血管通透性[1]。 DCZ19931 (500 nM; 24 h) 降低 HUVECs 中 p-ERK1/2、p-p38 和 p-JNK 的表达水平[1]。 DCZ19931 在小鼠脉络膜发芽试验中也显示出抗血管生成作用[1]。 Western Blot Analysis[1] Cell Line: Human umbilical vein endothelial cells (HUVECs) Concentration: 500 nM; with or without 50 ng/mL VEGF for 30 min Incubation Time: 24 hours Result: Decreased expression of phosphorylated ERK and phosphorylated p38.
In Vivo DCZ19931 (1 μL, 1 μg/μL; 静脉注射; 单剂量) 抑制小鼠氧诱导视网膜病变 (OIR) 模型眼新生血管生成[1]. DCZ19931 (2 μL, 1 μg/μL; 静脉注射; 7 d) 无组织毒性,并抑制激光诱导脉络膜新生血管 (CNV) 模型小鼠的眼部新生血管生成[1]。 Animal Model: Laser-induced choroidal neovascularization (CNV) model in mice[1] Dosage: 2 μL, 1 μg/μL Administration: Intravitreal injection; single dose, monitored for 7 d following laser photocoagulation Result: Did not cause marked histopathological changes in retinal structures. Decreased the areas of CNV lesions, showed anti-angiogenic effect in vivo. Animal Model: Oxygen-induced retinopathy (OIR) model in mice[1] Dosage: 1 μL, 1 μg/μL Administration: Intravitreal injection; single dose Result: Further showed anti-angiogenic effect in vivo, inhibited ocular neovascularization.
References

[1]. Zhang H, et al. DCZ19931, a novel multi-targeting kinase inhibitor, inhibits ocular neovascularization. Sci Rep. 2022 Dec 13;12(1):21539.  

Molecular Formula C26H20F5N3O5
Molecular Weight 549.45
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.